Buscar
Twist Bioscience Corp
TWSTAñadir a la lista de seguimiento
91.550USD
+0.220+0.24%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
5.69BCap. mercado
PérdidaP/E TTM
Más Datos de Twist Bioscience Corp Compañía
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
Información de Twist Bioscience Corp
Símbolo de cotizaciónTWST
Nombre de la empresaTwist Bioscience Corp
Fecha de salida a bolsaOct 31, 2018
Director ejecutivoLeproust (Emily M)
Número de empleados979
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 31
Dirección681 Gateway Blvd.
CiudadSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94080
Teléfono18007190671
Sitio Webhttps://www.twistbioscience.com/
Símbolo de cotizaciónTWST
Fecha de salida a bolsaOct 31, 2018
Director ejecutivoLeproust (Emily M)
Ejecutivos de Twist Bioscience Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.75K
-16.90%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
4.72K
-50.85%
Mr. Robert B. (Rob) Chess
Mr. Robert B. (Rob) Chess
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Twist Bioscience Corp?
Los cinco principales accionistas de Twist Bioscience Corp son: Dr. Emily M. Leproust, Ph.D.
¿Cuántas instituciones poseen acciones de Twist Bioscience Corp (TWST)?
A fecha de 2026Q1, 592 instituciones poseen acciones de Twist Bioscience Corp, con un valor de mercado combinado de aproximadamente 78.48M, lo que representa el 126.03% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -339291.00.
¿Cuál es la mayor fuente de ganancias de Twist Bioscience Corp?
El 2026Q1, el segmento empresarial NGS applications generó la ganancia más alta para Twist Bioscience Corp, ascendiendo a 52.64M y representando el 50.76% de la ganancia total.